Año 2019
61st ASH Annual Meeting and Exposition. Orlando Florida (USA). 7-9 diciembre, 2019
Germinal Predisposition in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction: Identification of Deleterious Variants in Microsatellite Instability
Tzu Hua Chen-Liang, Ana M Hurtado López, María Zurdo, Esperanza Such, Raul Teruel-Montoya, PhD, Laura Palomo, María-José Jimenez, MD, Rafael Andres del Orbe Barreto, Blanca Navarro, MD PhD, Félix López Cadenas, MD, Eduardo José Salido, MD, Carmen Benet, MD, Begoña Muiña, Raquel de Oña, Nuria de Haro, Fernando Ramos, MD, MPH, PhD, Montserrat Arnan Sangerman, Francisca Maria Hernandez, MD, Francisco José Ortuño, Leonor Senent, Ana Vicente, María Díez-Campelo, MD, PhD, Maria Lourdes Hermosin, MD, Teresa Bernal Del Castillo, MD, PhD, Mar Tormo, MD, PhD, Beatriz Arrizabalaga, Blanca Xicoy, PhD, José Cervera, MD, PhD, Francesc Sole, PhD, Guillermo F. Sanz, MD, PhD and Andres Jerez
Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study Group
Lisa Pleyer, Michael Leisch, MD, Alexandra Kourakli, MD, PhD, Eric Padron, MD, Jaroslaw P. Maciejewski, PhD, MD, FACP, Blanca Xicoy, MD, MSc, Jennifer Kaivers, MD, Johanna Ungerstedt, MD, PhD, Sonja Heibl, MD, Peristera Patiou, MD, Anthony M. Hunter, MD, Elvira Mora Casterá, MD, Klaus Geissler, MD, Maria Dimou, MD, PhD, María-José Jimenez, MD, David Kiesl, MD, Nora-Athina Viniou, MD, PhD, Bhumika J. Patel, MD, Montserrat Arnan Sangerman, Peter Valent, MD, Christoforos Roubakis, MD, Teresa Bernal del Castillo, MD, PhD, Athanasios Galanopoulos, MD, PhD, Marisa Calabuig, MD, Nicolas Bonadies, MD, Antonio Medina de Almeida, MD, PhD, Jaroslav Cermak, MD, PhD, Andres Jerez, Julia Montoro, MD, Albert Cortés, Alejandro Avendaño Pita, MD, Bernardo López Andrade, MD, Eva Hellstrom Lindberg, MD, PhD, Ulrich Germing, MD, Mikkael A. Sekeres, MD, MS Alan F. List, MD, Argiris Symeonidis, MD, PhD3 Guillermo F. Sanz, MD, PhD and Richard Greil, MD.
TP53 Status As Well As Cytogenetic Complexity Significantly Impact on Prognosis in Myelodysplastic Syndromes with Complex (>3 anomalies) Aberrant Karyotypes.
Christina Ganster1, Roxana Schaab1*, Katayoon Shirneshan1*, Lea Naomi Eder1*, Anna Mies2*, Ulrich Germing3*, Ahmet Elmaagacli4*, Francesc Sole5, Laura Palomo5*, Jennifer Kaivers3*, Ulrike Söling6*, Frank Lange7*, Nicolaus Kröger8*, Bernd Hertenstein9*, Konstanze Döhner10*, Gesine Bug11*, Barbara Hildebrandt12*, Marc Talló Parra1*, Maike Nickelsen13*, Bertram Glass14*, Uwe Platzbecker, Md15, Ulrike Bacher16*, Friederike Braulke1*, Julie Schanz1* And Detlef Haase1*.
Molecular Dissection of Del5q: Distinction Between Primary and Secondary Del(5q) and Pathogenetic Implications.
Vera Adema1,2, Laura Palomo2, Cassandra M. Kerr1, Wencke Walter3, Bartlomiej P Przychodzen1, Stephan Hutter3, Thomas Laframboise4, Maria Diez-campelo5, Mar Mallo2, Aziz Nazha6, Blanca Xicoy7, Manja Meggendorfer3, Hetty E. Carraway6, Claudia Haferlach3, Mikkael A. Sekeres6, Valeria Visconte1, Torsten Haferlach3, Francesc Sole2, Jaroslaw P. Maciejewski1
Can Monosomy 7 be Targeted by Next Generation Cereblon-Modulating Agents?
Vera Adema1, Cassandra M. Kerr1, Wencke Walter2, Stephan Hutter2, Yasunobu Nagata1, Hassan Awada1, Sunisa Kongkiatkamon1, Christina Snider1, Milo Co1, Magdalena Rainey1, Arda Durmaz1-3, Manja Meggendorfer2, Aziz Nazha4, Jacob G. Scott1, Hetty E. Carraway4, Mikkael A. Sekeres4, Francesc Sole6, Torsten Haferlach2, Valeria Visconte1, Jaroslaw P. Maciejewski1
Hotspot U2AF1 Mutations Determine Missplicing Selectivity: Novel Mechanisms Altering Splicing Factors.
Adema V, Hershberger C, Walter W, Kerr Cm, Hutter S, Nagata Y, Awada H, Kongkiatkamon S, Snider Ch, Co M, Meggendorfer M, Nazha A, Carraway He, Sekeres Ma, Sole F, Padgett R, Haferlach T, Maciejewski Jp, Visconte V.
Integrated Transcriptomic and Proteomic Analyses of Inflammasome in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
M Zurdo
Transcriptional and gene regulatory networks in the aging-clonal hematopoiesis-myelodysplatic syndromes axis as a tool for identifying novel therapeutic targets.
Dr. Felipe Prosper
Transcriptional regulation of Hematopoietic Stem Cells in Aging and Myelodysplastic Syndrome reveals DDIT3 as a Potential Driver of Transformation.
Teresa Ezponda1,2, Juan P. Romero1,2, Marina Ainciburu1,2, Ana Alfonso2,3, Nerea Berastegui1, Amaia Vilas1,2, Patxi San Martin1,2, Laura Castro1,2, Victoria Riego2,3, Tamara Jimenez4, Félix López4, Jesús M. Hernández4, Antonieta Molero5, Julia Montoro5, Bárbara Tazón5, Bruno Paiva2,6, María Díez-Campelo4, David Valcarcel5, David Lara1,2* and Felipe Prosper2,3*
Transfusion-Dependent Low Risk Myelodysplastic Syndrome (TD LR-MDS): Predictors Ofcardiovascular Events and Death
Marta Alonso Fernández de Gatta, MD PhD , Ana Martín García, MD PhD , Félix López Cadenas, MD , Díaz Peláez Elena, MD , Tamara Jimenez , Jesus Maria . Hernández-Rivas, MD , Victor Vallejo García, MD , Manuel Barreiro Pérez, MD , Lucia Rodríguez Estévez, MD , Juan Carlos Castro Garay , Diego Ávila, MD , Adolfo Alejandro Cabanillas Cabral, MD , Clara Sánchez Pablo, MD , María Díez-Campelo, MD PhD , Pedro Luís Sánchez Fernández, MD PhD.
Morphologic Assessment of Terminal Erythroid Differentiation Predicts Outcomes in Myelodysplastic Syndrome.
Dra. Julia Montoro
EHA 2019 Congress. Amsterdam (Países Bajos). 13-16 junio, 2019
Transcriptional and gene regulatory networks in the aging-clonal hematopoiesis-myelodysplatic syndromes axis as a tool for identifying novel therapeutic targets.
Dr. Felipe Prosper
Transcriptional alterations of hematopoietic stem cells in myelodysplastic syndromes.
Teresa Ezponda1,2, Juan Pablo Romero1,2, Marina Ainciburu1,2, Ana Alfonso2,3, Amaia Vilas1,2, Patxi San Martin1,2, Laura Castro1,2, Tamara Jimenez4, Félix López4, Jesús M. Hernández4, Antonieta Molero5, Julia Montoro5, Barbara Tazón5, Bruno Paiva2,6, Maria Díez-Campelo4, David Valcarcel5, Jesus San Miguel3, David Lara1,2* and Felipe Prosper2,3*
15th International Symposium on Myelodysplastic Syndromes. Copenhague (Dinamarca). 8-11 mayo, 2019
Analysis of the intratumoral heterogeneity in myelodysplastic syndromes associated with del(5q) using a single cell approach.
Pamela Acha, Laura Palomo, Francisco Fuster-Tormo, Blanca Xicoy, Mar Mallo, Paula Gómez-Marzo, Nuri de Haro, Javier Grau, Silvia Marcé, Lurdes Zamora, Francesc Solé.